Join thousands of book lovers
Sign up to our newsletter and receive discounts and inspiration for your next reading experience.
By signing up, you agree to our Privacy Policy.You can, at any time, unsubscribe from our newsletters.
Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade.
This book analyses the relationships among product safety strategy and culture, concurrent engineering, new product development (NPD) processes and product safety performance.
Sign up to our newsletter and receive discounts and inspiration for your next reading experience.
By signing up, you agree to our Privacy Policy.